- Home
- LEE vs CNTB Comparison
LEE vs CNTB Comparison
Compare LEE & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- CNTB
- Stock Information
- Founded
- LEE 1890
- CNTB 2012
- Country
- LEE United States
- CNTB United States
- Employees
- LEE N/A
- CNTB N/A
- Industry
- LEE Newspapers/Magazines
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- CNTB Health Care
- Exchange
- LEE Nasdaq
- CNTB Nasdaq
- Market Cap
- LEE 39.6M
- CNTB 54.4M
- IPO Year
- LEE N/A
- CNTB 2021
- Fundamental
- Price
- LEE $6.80
- CNTB $1.53
- Analyst Decision
- LEE
- CNTB Strong Buy
- Analyst Count
- LEE 0
- CNTB 2
- Target Price
- LEE N/A
- CNTB $7.50
- AVG Volume (30 Days)
- LEE 33.9K
- CNTB 154.8K
- Earning Date
- LEE 07-31-2025
- CNTB 09-04-2025
- Dividend Yield
- LEE N/A
- CNTB N/A
- EPS Growth
- LEE N/A
- CNTB N/A
- EPS
- LEE N/A
- CNTB N/A
- Revenue
- LEE $591,094,000.00
- CNTB $26,033,000.00
- Revenue This Year
- LEE N/A
- CNTB N/A
- Revenue Next Year
- LEE N/A
- CNTB N/A
- P/E Ratio
- LEE N/A
- CNTB N/A
- Revenue Growth
- LEE N/A
- CNTB N/A
- 52 Week Low
- LEE $5.83
- CNTB $0.51
- 52 Week High
- LEE $19.63
- CNTB $1.60
- Technical
- Relative Strength Index (RSI)
- LEE 54.12
- CNTB 66.20
- Support Level
- LEE $6.04
- CNTB $1.05
- Resistance Level
- LEE $7.00
- CNTB $1.20
- Average True Range (ATR)
- LEE 0.37
- CNTB 0.09
- MACD
- LEE 0.08
- CNTB 0.01
- Stochastic Oscillator
- LEE 82.91
- CNTB 82.76
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.